Other neuroprotective therapies on trial in acute stroke

Cerebrovascular Diseases

Volumn 21, Issue SUPPL. 2, 2006, Pages 127-130

  Ferro, José M ^a   Dávalos, Antoni ^b  

^a HOSPITAL DE SANTA MARIA   (Portugal)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Cerovive; Citicoline; Insulin; Interferon 1a; Magnesium; Neuroprotection; Piclozotan; Repinotan; Zonampanel

Indexed keywords

ALBUMIN; AMPA RECEPTOR ANTAGONIST; BETA1A INTERFERON; CITICOLINE; DISUFENTON SODIUM; GLUCOSE; GLUTAMATE RECEPTOR ANTAGONIST; INSULIN; MAGNESIUM; MAGNESIUM SULFATE; PICLOZOTAN; POTASSIUM; REPINOTAN; SEROTONIN 1A AGONIST; SEROTONIN ANTAGONIST; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; ZONAMPANEL;

ABSENCE OF SIDE EFFECTS; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN INFARCTION; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; HEADACHE; HUMAN; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STROKE;

ANTI-INFLAMMATORY AGENTS; BENZENESULFONATES; CEREBROVASCULAR ACCIDENT; DRUG COMBINATIONS; FREE RADICAL SCAVENGERS; GLUCOSE; HEMORRHAGE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INTERFERON-BETA; NEUROPROTECTIVE AGENTS; POTASSIUM; RANDOMIZED CONTROLLED TRIALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOMBINANT PROTEINS; STROKE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 33646481351     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091712     Document Type: Article

References (13)

1. Stroke Therapy Academic Industry Roundtable (STAIR). Stroke 1999;30:2752-2758.
2. Stroke Therapy Academic Industry Roundtable II (STAIR II). Stroke 2001;32:1598-1606.
3. Major ongoing stroke trials. Stroke 2005;36:e59-e67.
4. Trials directory of the Internet Stroke Center. www.strokecenter.org/ trials/
5. US National Institutes of Health. www.clinicaltrials.gov
6. Cochrane Central Register of Controlled Trials. http://gateway.ut.ovid. com/
7. European Stroke Initiative Executive Committee and the EUSI Writing Committee: European Stroke Initiative recommendations for stroke management - update 2003. Cerebrovasc Dis 2003;16:311-337.
8. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KG, Gray CS: Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST). Stroke 1999;30:793-799.
9. Muir KW, Lees KR, Ford I, Davis S, Intravenous Magnesium Efficacy in Stroke (IMAGES) Study Investigators: Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke Trial): randomised controlled trial. Lancet 2004;363:439-445.
10. Teal P, Silver FL, Simard D: The BRAINS study: safety, tolerability, and dose-finding of repinotan in acute stroke. Can J Neurol Sci 2005;32:61-67.
11. Teal P, Lyden P, Kaste M, Davis S, Hacke W, Fierus M: Effects of repinotan in patients with acute ischemic stroke: phase IIB modified randomized exposure controlled trial. Cerebrovasc Dis 2005;19(suppl 2):68.
12. Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, Shuaib A, Hardemark HG, Wasiewski W for the SAINT I Investigators: NXY-059 for Acute Ischaemic Stroke: the SAINT I Trial. N Engl J Med 2006;354:588-600.
13. Dávalos A, Castillo J, Álvarez-Sabín J, Secades JJ, Mercadal J, López S, Cobo E, Warach S, Sherman D, Clark WC, Lozano R: Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials. Stroke 2002;33:2850-2857.